ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 579,35
-0,70%
Dow Jones
40 211,72
0,53%
DAX
18 522,61
-0,42%
Brent Oil
83,585
-0,90%
Bitcoin
63 523,90
-2,05%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) Actualités

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
07/09/202110h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Present Clinical Data at ESMOLSE:0J7GHutchison China Meditech Ltd
06/09/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Shares Included in Stock Connect ProgramsLSE:0J7GHutchison China Meditech Ltd
02/09/202113h45UK RegulatoryHutchmed (China) Limited Grant of Share Options, and Awards under LTIPLSE:0J7GHutchison China Meditech Ltd
31/08/202110h30UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
26/08/202108h00RNS Non-RegulatoryHutchmed (China) Limited Phase Ib/II Trial of Fruquintinib & TislelizumabLSE:0J7GHutchison China Meditech Ltd
23/08/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Selected for Certain Hang Seng IndexesLSE:0J7GHutchison China Meditech Ltd
17/08/202110h30UK RegulatoryHutchmed (China) Limited ELECTRONIC COMMUNICATION OF CORPORATE INFORMATIONLSE:0J7GHutchison China Meditech Ltd
09/08/202108h00UK RegulatoryHutchmed (China) Limited HUTCHMED & Epizyme Announce TAZVERIK CollaborationLSE:0J7GHutchison China Meditech Ltd
28/07/202113h00UK RegulatoryHutchmed (China) Limited Interim Results and Business UpdatesLSE:0J7GHutchison China Meditech Ltd
28/07/202108h00RNS Non-RegulatoryHutchmed (China) Limited Phase II Trial of ORPATHYS InitiatedLSE:0J7GHutchison China Meditech Ltd
23/07/202113h01UK RegulatoryHutchmed (China) Limited Stabilizing Actions & End of Stabilization PeriodLSE:0J7GHutchison China Meditech Ltd
16/07/202111h50UK RegulatoryHutchmed (China) Limited Holding(s) in CompanyLSE:0J7GHutchison China Meditech Ltd
16/07/202108h00RNS Non-RegulatoryHutchmed (China) Limited Surufatinib MAA Submitted and Validated by the EMALSE:0J7GHutchison China Meditech Ltd
13/07/202108h00RNS Non-RegulatoryHutchmed (China) Limited First Commercial Sale of ORPATHYS(R) in ChinaLSE:0J7GHutchison China Meditech Ltd
12/07/202115h35UK RegulatoryHutchmed (China) Limited Full Exercise of the Over-allotment OptionLSE:0J7GHutchison China Meditech Ltd
06/07/202110h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Initiates Phase I Trials of HMPL-295LSE:0J7GHutchison China Meditech Ltd
02/07/202110h30UK RegulatoryHutchmed (China) Limited Notice of ResultsLSE:0J7GHutchison China Meditech Ltd
01/07/202112h00RNS Non-RegulatoryHutchmed (China) Limited US FDA Accepts NDA Filing for SurufatinibLSE:0J7GHutchison China Meditech Ltd
30/06/202111h02UK RegulatoryHutchmed (China) Limited Holdings in CompanyLSE:0J7GHutchison China Meditech Ltd
30/06/202111h00UK RegulatoryHutchmed (China) Limited Closing of Global Offering and Hong Kong ListingLSE:0J7GHutchison China Meditech Ltd
29/06/202108h00UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
23/06/202116h21UK RegulatoryHutchmed (China) Limited HUTCHMED Announces Pricing of Global OfferingLSE:0J7GHutchison China Meditech Ltd
22/06/202119h22UK RegulatoryHutchmed (China) Limited Savolitinib approved in China for lung cancerLSE:0J7GHutchison China Meditech Ltd
18/06/202117h05UK RegulatoryHutchmed (China) Limited HUTCHMED Announces NMPA Approval of SurufatinibLSE:0J7GHutchison China Meditech Ltd
18/06/202108h01UK RegulatoryHutchmed (China) Limited HUTCHMED Launches Hong Kong IPOLSE:0J7GHutchison China Meditech Ltd
18/06/202108h00UK RegulatoryHutchmed (China) Limited Disclosure UpdateLSE:0J7GHutchison China Meditech Ltd
20/05/202108h00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ASCO21LSE:0J7GHutchison China Meditech Ltd
17/05/202108h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Host Company UpdateLSE:0J7GHutchison China Meditech Ltd
07/05/202113h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED to Attend Upcoming Investor ConferencesLSE:0J7GHutchison China Meditech Ltd
04/05/202109h00UK RegulatoryHutchison China Meditech Limited Change of Company NameLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
EU
LR
Legrand
EU
CS
Axa
EU
RNO
Renault
EU
SGO
Cie de SaintGobain
NYSE
MCD
McDonalds
EU
DG
Vinci
EU
BEL20
Bel 20
USI
USTECH100
US Tech 100
EU
VK
Vallourec
EU
HO
Thales
EU
VIV
Vivendi
EU
PX4
SBF 120
FTSE
UKX
FTSE 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés